Anabolic therapy in glucocorticoid-induced osteoporosis

被引：25

作者：

Sambrook, Philip N. ^{[1
]}

机构：

[1] Univ Sydney, Kolling Inst, Sydney, NSW 2006, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 20期

关键词：

D O I：

10.1056/NEJMe0706770

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2084 / 2086

页数：3

共 10 条

[1] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].

Adachi, JD ;

Bensen, WG ;

Brown, J ;

Hanley, D ;

Hodsman, A ;

Josse, R ;

Kendler, DL ;

Lentle, B ;

Olszynski, W ;

SteMarie, LG ;

Tenenhouse, A ;

Chines, AA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387

[2] Glucocorticoid-induced osteoporosis: pathophysiology and therapy [J].

Canalis, E. ;

Mazziotti, G. ;

Giustina, A. ;

Bilezikian, J. P. .

OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) :1319-1328

[3] Vertebral fracture risk with long-term corticosteroid therapy -: Prevalence and relation to age, bone density, and corticosteroid use [J].

Naganathan, V ;

Jones, G ;

Nash, P ;

Nicholson, G ;

Eisman, J ;

Sambrook, PN .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) :2917-2922

[4] Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts [J].

Ohnaka, K ;

Tanabe, M ;

Kawate, H ;

Nawata, H ;

Takayanagi, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) :177-181

[5] Teriparatide or alendronate in glucocorticoid-induced osteoporosis [J].

Saag, Kenneth G. ;

Shane, Elizabeth ;

Boonen, Steven ;

Marin, Fernando ;

Donley, David W. ;

Taylor, Kathleen A. ;

Dalsky, Gail P. ;

Marcus, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) :2028-2039

[6] Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis [J].

Saag, KG ;

Emkey, R ;

Schnitzer, TJ ;

Brown, JP ;

Hawkins, F ;

Goemaere, S ;

Thamsborg, G ;

Liberman, UA ;

Delmas, PD ;

Malice, MP ;

Czachur, M ;

Daifotis, AG .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :292-299

[7] Osteocyte viability with glucocorticoid treatment: relation to histomorphometry [J].

Sambrook, PN ;

Hughes, DR ;

Nelson, AE ;

Robinson, BG ;

Mason, RS .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (12) :1215-1217

[8] Use of oral corticosteroids and risk of fractures [J].

Van Staa, TP ;

Leufkens, HGM ;

Abenhaim, L ;

Zhang, B ;

Cooper, C .

JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (06) :993-1000

[9] Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy [J].

Wallach, S ;

Cohen, S ;

Reid, DM ;

Hughes, RA ;

Hosking, DJ ;

Laan, RF ;

Doherty, SM ;

Maricic, M ;

Rosen, C ;

Brown, J ;

Barton, I ;

Chines, AA .

CALCIFIED TISSUE INTERNATIONAL, 2000, 67 (04) :277-285

[10] Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids - Potential mechanisms of their deleterious effects on bone [J].

Weinstein, RS ;

Jilka, RL ;

Parfitt, AM ;

Manolagas, SC .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (02) :274-282

← 1 →